Multimodal Imaging Signatures of Parkinson's Disease.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 27147942)

Published in Front Neurosci on April 18, 2016

Authors

F DuBois Bowman1, Daniel F Drake1, Daniel E Huddleston2

Author Affiliations

1: Department of Biostatistics, The Mailman School of Public Health, Columbia University New York, NY, USA.
2: Department of Neurology, Emory University Atlanta, GA, USA.

Articles cited by this

AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res (1996) 53.52

Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage (2002) 49.90

Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage (2004) 49.54

Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging (2002) 22.40

Probabilistic diffusion tractography with multiple fibre orientations: What can we gain? Neuroimage (2006) 12.78

Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain (1991) 8.16

An improved approach to detection of amplitude of low-frequency fluctuation (ALFF) for resting-state fMRI: fractional ALFF. J Neurosci Methods (2008) 4.25

How to correct susceptibility distortions in spin-echo echo-planar images: application to diffusion tensor imaging. Neuroimage (2003) 3.57

The anatomical connections of the macaque monkey orbitofrontal cortex. A review. Cereb Cortex (2000) 3.24

High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease. Neurology (2009) 3.04

Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study. Lancet Neurol (2013) 2.30

Parkinson's disease. Lancet (2015) 2.14

What are biomarkers? Curr Opin HIV AIDS (2010) 1.80

Dysfunction of the default mode network in Parkinson disease: a functional magnetic resonance imaging study. Arch Neurol (2009) 1.49

Combined R2* and diffusion tensor imaging changes in the substantia nigra in Parkinson's disease. Mov Disord (2011) 1.44

Analyzing complex functional brain networks: Fusing statistics and network science to understand the brain(*†) Stat Surv (2013) 1.28

Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease. Brain (2002) 1.27

Altered resting state brain networks in Parkinson's disease. PLoS One (2013) 1.25

Resting state functional MRI in Parkinson's disease: the impact of deep brain stimulation on 'effective' connectivity. Brain (2014) 1.10

Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: a multicenter study. Ann Neurol (2015) 1.08

Cortical thinning is associated with disease stages and dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry (2013) 1.07

Amygdala pathology in Parkinson's disease. Acta Neuropathol (1994) 0.99

Progress in defining the premotor phase of Parkinson's disease. J Neurol Sci (2011) 0.97

Dysfunction of the locus coeruleus-norepinephrine system and related circuitry in Parkinson's disease-related dementia. J Neurol Neurosurg Psychiatry (2012) 0.96

The critical need for defining preclinical biomarkers in Alzheimer's disease. Alzheimers Dement (2014) 0.92

Neural substrates of motor and non-motor symptoms in Parkinson's disease: a resting FMRI study. PLoS One (2015) 0.86

Abnormal functional connectivity of the amygdala is associated with depression in Parkinson's disease. Mov Disord (2014) 0.86

Early cortical gray matter loss and cognitive correlates in non-demented Parkinson's patients. Parkinsonism Relat Disord (2013) 0.84

Magnetic resonance morphometry of the loss of gray matter volume in Parkinson's disease patients. Neural Regen Res (2013) 0.81

Novel recruitment strategy to enrich for LRRK2 mutation carriers. Mol Genet Genomic Med (2015) 0.77